Combination neural and mesenchymal stem cell therapy: Pilot trial started

Novastem began a Mexican pilot trial to evaluate combination neural and mesenchymal stem cell therapy in about 30 patients. Subjects will receive 90 million neural stem cells on day 1 and 90 million m...